The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Role of AMP-activated protein kinase in mechanism of metformin action
Open accessAbstract
Metformin is a widely used drug for treatment of type 2 diabetes with no defined cellular mechanism of action. Its glucose-lowering effect results from decreased hepatic glucose production and increased glucose utilization. Metformin's beneficial effects on circulating lipids have been linked to reduced fatty liver. AMP-activated protein kinase (AMPK) is a major cellular regulator of lipid and glucose metabolism. Here we report that metformin activates AMPK in hepatocytes; as a result, acetyl-CoA carboxylase (ACC) activity is reduced, fatty acid oxidation is induced, and expression of lipogenic enzymes is suppressed. Activation of AMPK by metformin or an adenosine analogue suppresses expression of SREBP-1, a key lipogenic transcription factor. In metformin-treated rats, hepatic expression of SREBP-1 (and other lipogenic) mRNAs and protein is reduced; activity of the AMPK target, ACC, is also reduced. Using a novel AMPK inhibitor, we find that AMPK activation is required for metformin's inhibitory effect on glucose production by hepatocytes. In isolated rat skeletal muscles, metformin stimulates glucose uptake coincident with AMPK activation. Activation of AMPK provides a unified explanation for the pleiotropic beneficial effects of this drug; these results also suggest that alternative means of modulating AMPK should be useful for the treatment of metabolic disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“However, being a nonspecific inhibitor of oxidative phosphorylation [674, 675]”
From Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition) 1 (2021) · cites this paper as [675]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredIn the citing paper
“AMPK is activated through metabolic stress and acts as a cellular regulator of lipid and glucose metabolism (102, 103).”
From A Critical Review of the Evidence That Metformin Is a Putative Anti-Aging Drug That Enhances Healthspan and Extends Lifespan (2021) · cites this paper as [102]
In the citing paper
“It is also activated by the antidiabetic drugs metformin and rosiglitazone (21-23), and by the adipocyte-derived hormones leptin and adiponectin (24, 25).”
From CBS domains form energy-sensing modules whose binding of adenosine ligands is disrupted by disease mutations (2004) · cites this paper as [21]
In the citing paper
“it has even been shown to stimulate autophagy by an AMP-independent mechanism [675, 678]”
From Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition) 1 (2021) · cites this paper as [675]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
OWEN, M. R., DORAN, E., & HALESTRAP, A. P. (2000) · Biochemical Journal · doi:10.1042/bj3480607 · Cited by 2,157
The Mitochondrial Carnitine Palmitoyltransferase System — From Concept to Molecular Analysis
McGarry, J. D., & Brown, N. F. (1997) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1997.00001.x · Cited by 1,616 · cited 1×
“Malonyl-CoA is an initial substrate for de novo fatty acid biosynthesis, and it serves as a potent inhibitor of carnitine palmitoyl transferase I (CPT-I), a rate-limiting step for fatty acid oxidation (34).”
BackgroundEl-Mir, M.-Y., Nogueira, V., Fontaine, E., Avéret, N., Rigoulet, M., & Leverve, X. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.1.223 · Cited by 1,399
The AMP‐Activated Protein Kinase: Fuel Gauge of the Mammalian Cell?
Hardie, D. G., & Carling, D. (1997) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1997.00259.x · Cited by 1,317
Metabolic effects of metformin in non-insulin-dependent diabetes mellitus
Stumvoll, M., Nurjhan, N., Perriello, G., Dailey, G., & Gerich, J. E. (1995) · New England Journal of Medicine · doi:10.1056/nejm199508313330903 · Cited by 1,148
Mechanism by which metformin reduces glucose production in type 2 diabetes.
Hundal, R. S., Krssak, M., Dufour, S., Laurent, D., Lebon, V, Chandramouli, V, Inzucchi, S. E., Schumann, W. C., Petersen, K. F., Landau, B. R., et al. (2000) · Diabetes · doi:10.2337/diabetes.49.12.2063 · Cited by 1,052 · cited 2×
“It is believed that metformin-mediated inhibition of hepatic glucose production (HGP) plays a major role in its glucose-lowering efficacy (2, 3, 6).”
BackgroundMerrill, G. F., Kurth, E. J., Hardie, D. G., & Winder, W. W. (1997) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1997.273.6.e1107 · Cited by 1,048
AMP-activated protein kinase, a metabolic master switch: possible roles in Type 2 diabetes
Winder, W. W., & Hardie, D. G. (1999) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1999.277.1.e1 · Cited by 1,000
Shimomura, I., Matsuda, M., Hammer, R. E., Bashmakov, Y. K., Brown, M. S., & Goldstein, J. L. (2000) · Molecular Cell · doi:10.1016/s1097-2765(05)00010-9 · Cited by 860
Hayashi, T., Hirshman, M. F., Kurth, E. J., Winder, W. W., & Goodyear, L. J. (1998) · Diabetes · doi:10.2337/diab.47.8.1369 · Cited by 774
Self-citation
Research works printed but not linked: 11
- Schafer, 1983, Diabete Metab, 9, 148
- 10.1210/en.131.3.1165 · DOI
- Winder, 1999, Am J Physiol, 277, E1
- Merrill, 1997, Am J Physiol, 273, E1107
- Goodyear, 2000, Exerc Sport Sci Rev, 28, 113
- Cusi, 1998, Diabetes Reviews, 6, 89
- Wiernsperger, 1999, Diabetes Metab, 25, 110
- Hermann, 1979, Diabete Metab, 5, 233
- Sterne, 1979, Research Clinical Forums, 1, 13
- 10.1042/0264-6021:3480607 · DOI · Paper page
- 10.1016/S1097-2765(00)00009-5 · DOI
Cited by
Sorted by citations
Items 501–600 of 1,066
AMPK and autophagy in glucose/glycogen metabolism
Ha, J., Guan, K., & Kim, J. (2015) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2015.08.002 · Cited by 219
Tsuda, T., Ueno, Y., Aoki, H., Koda, T., Horio, F., Takahashi, N., Kawada, T., & Osawa, T. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.02.031 · Cited by 213
Metformin Antagonizes Cancer Cell Proliferation by Suppressing Mitochondrial-Dependent Biosynthesis
Griss, T., Vincent, E. E., Egnatchik, R. A., Chen, J., Ma, E. H., Faubert, B., Viollet, B., DeBerardinis, R. J., & Jones, R. G. (2015) · PLoS Biology · doi:10.1371/journal.pbio.1002309 · Cited by 216
Cytochrome c phosphorylation: Control of mitochondrial electron transport chain flux and apoptosis
Kalpage, H. A., Wan, J., Morse, P. T., Zurek, M. P., Turner, A. A., Khobeir, A., Yazdi, N., Hakim, L., Liu, J., Vaishnav, A., et al. (2020) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2020.105704 · Cited by 213
Suwa, M., Egashira, T., Nakano, H., Sasaki, H., & Kumagai, S. (2006) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00255.2006 · Cited by 210
The Impact of Diabetes and Diabetes Medications on Bone Health
Gilbert, M. P., & Pratley, R. E. (2015) · Endocrine Reviews · doi:10.1210/er.2012-1042 · Cited by 211
A novel direct activator of AMPK inhibits prostate cancer growth by blocking lipogenesis
Zadra, G., Photopoulos, C., Tyekucheva, S., Heidari, P., Weng, Q. P., Fedele, G., Liu, H., Scaglia, N., Priolo, C., Sicińska, E., et al. (2014) · EMBO Molecular Medicine · doi:10.1002/emmm.201302734 · Cited by 216
Nandipati, K. C., Subramanian, S., & Agrawal, D. K. (2016) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-016-2878-8 · Cited by 214
Fibroblast Growth Factor-19, a Novel Factor That Inhibits Hepatic Fatty Acid Synthesis
Bhatnagar, S., Damron, H. A., & Hillgartner, F. B. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m808818200 · Cited by 212
Metformin and cancer hallmarks: shedding new lights on therapeutic repurposing
Hua, Y., Zheng, Y., Yao, Y., Jia, R., Ge, S., & Zhuang, A. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-04263-8 · Cited by 220
Metformin: A Therapeutic Opportunity in Breast Cancer
Gonzalez-Angulo, A. M., & Meric‐Bernstam, F. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-1805 · Cited by 211
Agonist-modulated Regulation of AMP-activated Protein Kinase (AMPK) in Endothelial Cells
Levine, Y. C., Li, G. K., & Michel, T. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m702182200 · Cited by 207
Bhamra, G. S., Hausenloy, D. J., Davidson, S. M., Carr, R. D., Paiva, M. S. A., Wynne, A. M., Mocanu, M. M., & Yellon, D. M. (2007) · Basic Research in Cardiology · doi:10.1007/s00395-007-0691-y · Cited by 211
Zhang, H., Zhai, Z., Wang, Y., Zhang, J., Wu, H., Wang, Y., Li, C., Li, D., Lu, L., Wang, X., et al. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.10.530 · Cited by 212
Song, X., Zhong, L., Lyu, N., Liu, F., Li, B., Hao, Y., Xue, Y., Li, J., Feng, Y., Ma, Y., et al. (2019) · Genomics Proteomics & Bioinformatics · doi:10.1016/j.gpb.2019.03.001 · Cited by 209
Son, H.-J., Lee, J., Lee, S.-Y., Kim, E.-K., Park, M.-J., Kim, K.-W., Park, S.-H., & Cho, M.-L. (2014) · Mediators of Inflammation · doi:10.1155/2014/973986 · Cited by 206
Hao, J., Daleo, M. A., Murphy, C. K., Yu, P. B., Ho, J. N., Hu, J., Peterson, R. T., Hatzopoulos, A. K., & Hong, C. C. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002904 · Cited by 208
Liver-Specific Activation of AMPK Prevents Steatosis on a High-Fructose Diet
Woods, A., Williams, J., Muckett, P. J., Mayer, F. V., Liljevald, M., Bohlooly‐Y, M., & Carling, D. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.03.011 · Cited by 211
Sozio, M. S., & Crabb, D. W. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00011.2008 · Cited by 207
Chen, L., Pawlikowski, B. T., Schlessinger, A., More, S. S., Stryke, D., Johns, S. J., Portman, M. A., Chen, E., Ferrin, T. E., Šali, A., et al. (2010) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e32833fe789 · Cited by 205
Metformin Decreases Intracellular Production of Reactive Oxygen Species in Aortic Endothelial Cells
Ouslimani, N., Peynet, J., Bonnefont-Rousselot, D., Thérond, P., Legrand, A., & Beaudeux, J.-L. (2005) · Metabolism · doi:10.1016/j.metabol.2005.01.029 · Cited by 204
Bergheim, I., Guo, L., Davis, M. A., Lambert, J. C., Beier, J. I., Duveau, I., Luyendyk, J. P., Roth, R. A., & Arteel, G. E. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.03.020 · Cited by 204
Dual antiglioma action of metformin: cell cycle arrest and mitochondria-dependent apoptosis
Isaković, A., Harhaji-Trajkovic, L. M., Stevanovic, D., Marković, Z. M., Šumarac-Dumanović, M., Starcevic, V. P., Micić, D., & Trajković, V. (2007) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-007-7080-4 · Cited by 210
Entosis Is Induced by Glucose Starvation
Hamann, J. C., Surcel, A., Chen, R., Teragawa, C., Albeck, J. G., Robinson, D. N., & Overholtzer, M. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.06.037 · Cited by 203
Targeting Cancer Metabolism: Dietary and Pharmacologic Interventions
Vernieri, C., Casola, S., Foiani, M., Pietrantonio, F., de Braud, F., & Longo, V. (2016) · Cancer Discovery · doi:10.1158/2159-8290.cd-16-0615 · Cited by 202
Hou, X., Song, J., Li, X., Zhang, L., Wang, X., Chen, L., & Shen, Y. H. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.04.017 · Cited by 206
Current understanding of metformin effect on the control of hyperglycemia in diabetes
An, H., & He, L. (2016) · Journal of Endocrinology · doi:10.1530/joe-15-0447 · Cited by 205
Metformin extends C. elegans lifespan through lysosomal pathway
Chen, J., Ou, Y., Li, Y., Hu, S., Shao, L.-W., & Liu, Y. (2017) · eLife · doi:10.7554/elife.31268 · Cited by 207
Self-citationTherapeutic host-directed strategies to improve outcome in tuberculosis
Young, C., Walzl, G., & du Plessis, N. (2019) · Mucosal Immunology · doi:10.1038/s41385-019-0226-5 · Cited by 202
Metformin in COVID-19: A possible role beyond diabetes
Sharma, S., Ray, A., & Sadasivam, B. (2020) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2020.108183 · Cited by 202
The role of AMPK in macrophage metabolism, function and polarisation
Cui, Y., Chen, J., Zhang, Z., Shi, H., Sun, W., & Yi, Q. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-04772-6 · Cited by 213
Apostolova, N., Iannantuoni, F., Gruevska, A., Muntané, J., Rocha, M., & Víctor, V. M. (2020) · Redox Biology · doi:10.1016/j.redox.2020.101517 · Cited by 208
Bryrup, T., Thomsen, C. W., Kern, T., Allin, K. H., Brandslund, I., Jørgensen, N. R., Vestergaard, H., Hansen, T., Hansen, T. H., Pedersen, O., et al. (2019) · Diabetologia · doi:10.1007/s00125-019-4848-7 · Cited by 200
Expanding role of AMPK in endocrinology
Kola, B., Boscaro, M., Rutter, G. A., Grossman, A. B., & Korbonits, M. (2006) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2006.05.006 · Cited by 200
Green, A. S., Chapuis, N., Trovati Maciel, T., Willems, L., Lambert, M., Arnoult, C., Boyer, O., Bardet, V., Park, S., Foretz, M., et al. (2010) · Blood · doi:10.1182/blood-2010-02-269837 · Cited by 199
Slack, C., Foley, A., & Partridge, L. (2012) · PLoS ONE · doi:10.1371/journal.pone.0047699 · Cited by 199
Critical role of AMPK in redox regulation under glucose starvation
Ren, Y., & Shen, H. (2019) · Redox Biology · doi:10.1016/j.redox.2019.101154 · Cited by 201
Metformin in Breast Cancer: Time for Action
Goodwin, P. J., Ligibel, J. A., & Stambolic, V. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.22.1630 · Cited by 199
Redox implications of AMPK-mediated signal transduction beyond energetic clues
Cardaci, S., Filomeni, G., & Ciriolo, M. R. (2012) · Journal of Cell Science · doi:10.1242/jcs.095216 · Cited by 204
AMPK functions as an adenylate charge-regulated protein kinase
Oakhill, J. S., Scott, J. W., & Kemp, B. E. (2012) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2011.12.006 · Cited by 201
Heijman, J., Algalarrondo, V., Voigt, N., Melka, J., Wehrens, X. H. T., Dobrev, D., & Nattel, S. (2015) · Cardiovascular Research · doi:10.1093/cvr/cvv275 · Cited by 198
Gonzalez, A., Krieg, R. J., Massey, H. D., Carl, D. E., Ghosh, S., Gehr, T. W. B., & Ghosh, S. S. (2018) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfy238 · Cited by 203
Chemoprevention of Colorectal Cancer
Katona, B. W., & Weiss, J. M. (2019) · Gastroenterology · doi:10.1053/j.gastro.2019.06.047 · Cited by 201
Feng, J., Wang, X., Ye, X., Arés, I., López-Torres, B., Martínez, M., Martínez‐Larrañaga, M., Wang, X., Anadón, A., & Martínez, M. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106114 · Cited by 201
Metformin suppresses hepatic gluconeogenesis through induction of SIRT1 and GCN5
Caton, P., Nayuni, N. K., Kieswich, J. E., Khan, N. Q., Yaqoob, M. M., & Corder, R. (2010) · Journal of Endocrinology · doi:10.1677/joe-09-0345 · Cited by 203
Resveratrol, sirtuins, and the promise of a DR mimetic
Baur, J. A. (2010) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2010.02.007 · Cited by 202
Metformin in aging and aging-related diseases: clinical applications and relevant mechanisms
Chen, S., Gan, D., Lin, S., Zhong, Y., Chen, M., Zou, X., Shao, Z., & Xiao, G. (2022) · Theranostics · doi:10.7150/thno.71360 · Cited by 205
Pathogenesis of ataxia-telangiectasia: the next generation of ATM functions
Ambrose, M., & Gatti, R. A. (2013) · Blood · doi:10.1182/blood-2012-09-456897 · Cited by 196
Phosphorylation of EZH2 by AMPK Suppresses PRC2 Methyltransferase Activity and Oncogenic Function
Wan, L., Xu, K., Wei, Y., Zhang, J., Han, T., Fry, C. J., Zhang, Z., Wang, Y. V., Huang, L., Yuan, M., et al. (2018) · Molecular Cell · doi:10.1016/j.molcel.2017.12.024 · Cited by 200
RetractedKinase signalling pathways in endometriosis: potential targets for non-hormonal therapeutics
McKinnon, B. D., Kocbek, V., Nirgianakis, K., Bersinger, N. A., & Mueller, M. D. (2016) · Human Reproduction Update · doi:10.1093/humupd/dmv060 · Cited by 195
Jia, J., Bissa, B., Brecht, L., Allers, L., Choi, S. W., Gu, Y., Zbinden, M., Burge, M. R., Timmins, G. S., Hallows, K. R., et al. (2020) · Molecular Cell · doi:10.1016/j.molcel.2019.12.028 · Cited by 198
Molecular Mechanism of Insulin Resistance and Obesity
Kadowaki, T., Hara, K., Yamauchi, T., Terauchi, Y., Tobe, K., & Nagai, R. (2003) · Experimental Biology and Medicine · doi:10.1177/153537020322801003 · Cited by 198
Mitochondrial Hormesis and Diabetic Complications
Sharma, K. (2015) · Diabetes · doi:10.2337/db14-0874 · Cited by 194
Horike, N., Sakoda, H., Kushiyama, A., Ono, H., Fujishiro, M., Kamata, H., Nishiyama, K., Uchijima, Y., Kurihara, Y., Kurihara, H., et al. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m802537200 · Cited by 197
AMP-activated protein kinase (AMPK) activation regulates in vitro bone formation and bone mass
Shah, M., Kola, B., Bataveljic, A., Arnett, T. R., Viollet, B., Saxon, L., Korbonits, M., & Chenu, C. (2010) · Bone · doi:10.1016/j.bone.2010.04.596 · Cited by 196
Desjardins, E. M., & Steinberg, G. R. (2018) · Current Diabetes Reports · doi:10.1007/s11892-018-1049-6 · Cited by 193
Resveratrol as a calorie restriction mimetic: therapeutic implications
Chung, J. H., Manganiello, V., & Dyck, J. R. B. (2012) · Trends in Cell Biology · doi:10.1016/j.tcb.2012.07.004 · Cited by 192
STOCKER, S. L., Morrissey, K. M., Yee, S. W., Castro, R. A., Xu, L., Dahlin, A., Ramirez, A. H., Roden, D. M., Wilke, R. A., McCarty, C. A., et al. (2012) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2012.210 · Cited by 195
Counteracting Roles of AMP Deaminase and AMP Kinase in the Development of Fatty Liver
Lanaspa, M. A., Cicerchi, C., García, G., Li, N., Roncal-Jiménez, C. A., Rivard, C. J., Hunter, B., Andrés-Hernando, A., Ishimoto, T., Sánchez‐Lozada, L. G., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0048801 · Cited by 192
Kim, J., Kwak, H. J., Cha, J.-Y., Jeong, Y.-S., Rhee, S. D., Kim, K. R., & Cheon, H. G. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.577908 · Cited by 197
Osteoarthritis year in review 2020: biology
van den Bosch, M. H. J. (2020) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2020.10.006 · Cited by 192
Should metformin remain the first-line therapy for treatment of type 2 diabetes?
Baker, C., Retzik-Stahr, C., Singh, V., Plomondon, R., Anderson, V., & Rasouli, N. (2021) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/2042018820980225 · Cited by 204
Setter, S. M., Iltz, J. L., Thams, J., & Campbell, R. K. (2003) · Clinical Therapeutics · doi:10.1016/s0149-2918(03)90089-0 · Cited by 193
Astaxanthin protects mitochondrial redox state and functional integrity against oxidative stress
Wolf, A. M., Asoh, S., Hiranuma, H., Ohsawa, I., Iio, K., Satou, A., Ishikura, M., & Ohta, S. (2009) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2009.01.011 · Cited by 191
Roles of AMP-activated Protein Kinase in Alzheimer’s Disease
Cai, Z., Yan, L., Li, K., Quazi, S. H., & Zhao, B. (2012) · NeuroMolecular Medicine · doi:10.1007/s12017-012-8173-2 · Cited by 198
Theaflavins attenuate hepatic lipid accumulation through activating AMPK in human HepG2 cells
Lin, C., Huang, H., & Lin, J. (2007) · Journal of Lipid Research · doi:10.1194/jlr.m700128-jlr200 · Cited by 194
Mitochondrial dysfunction and complications associated with diabetes
Blake, R., & Trounce, I. A. (2014) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2013.11.007 · Cited by 190
Lévy, J., Cacheux, W., Bara, M. A., L’Hermitte, A., Lepage, P., Fraudeau, M., Trentesaux, C., Lemarchand, J., Durand, A., Crain‐Denoyelle, A., et al. (2015) · Nature Cell Biology · doi:10.1038/ncb3206 · Cited by 200
mTOR inhibition: A promising strategy for stabilization of atherosclerotic plaques
Martinet, W., Loof, H. D., & Meyer, G. R. Y. D. (2014) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2014.01.040 · Cited by 190
Jang, W. G., Kim, E., Bae, I.-H., Lee, K.-N., Kim, Y. D., Kim, D., Kim, S.-H., Lee, C., Franceschi, R. T., Choi, H., et al. (2010) · Bone · doi:10.1016/j.bone.2010.12.003 · Cited by 192
Metabolic Regulation of Neuronal Plasticity by the Energy Sensor AMPK
Potter, W. B., O’Riordan, K. J., Barnett, D. G. S., Osting, S., Wagoner, M. P., Bürger, C., & Roopra, A. (2010) · PLoS ONE · doi:10.1371/journal.pone.0008996 · Cited by 195
The ratio of leptin to adiponectin can be used as an index of insulin resistance
Oda, N., Imamura, S., Fujita, T., Uchida, Y., Inagaki, K., Kakizawa, H., Hayakawa, N., Suzuki, A., Takeda, J., Horikawa, Y., et al. (2008) · Metabolism · doi:10.1016/j.metabol.2007.09.011 · Cited by 194
The Role of AMPK Activation for Cardioprotection in Doxorubicin-Induced Cardiotoxicity
Timm, K. N., & Tyler, D. J. (2020) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-020-06941-x · Cited by 192
Fey, S. J., & Wrzesinski, K. (2012) · Toxicological Sciences · doi:10.1093/toxsci/kfs122 · Cited by 188
Leptin regulates tau phosphorylation and amyloid through AMPK in neuronal cells
Greco, S. J., Sarkar, S., Johnston, J. M., & Tezapsidis, N. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.01.041 · Cited by 190
Regulation of neuron mitochondrial biogenesis and relevance to brain health
Onyango, I. G., Lu, J., Rodova, M., Lezi, E., Crafter, A. B., & Swerdlow, R. H. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2009.07.014 · Cited by 190
Kang, S., Dahl, R. S., Hsieh, W., Shin, A. C., Zsebo, K. M., Buettner, C., Hajjar, R. J., & Lebeche, D. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.705012 · Cited by 193
Yu, J., Deng, Y., Han, X., Ren, G., Cai, J., & Jiang, G. (2016) · Cardiovascular Diabetology · doi:10.1186/s12933-016-0408-3 · Cited by 188
The lysosome: a crucial hub for AMPK and mTORC1 signalling
Carroll, B., & Dunlop, E. A. (2017) · Biochemical Journal · doi:10.1042/bcj20160780 · Cited by 192
AMP-activated protein kinase: Also regulated by ADP?
Hardie, D. G., Carling, D., & Gamblin, S. J. (2011) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2011.06.004 · Cited by 187
Structural Basis for Glycogen Recognition by AMP-Activated Protein Kinase
Polekhina, G., Gupta, A., van Denderen, B. J. W., Feil, S. C., Kemp, B. E., Stapleton, D., & Parker, M. W. (2005) · Structure · doi:10.1016/j.str.2005.07.008 · Cited by 191
Evans, A. M., Mustard, K. J. W., Wyatt, C. N., Peers, C., Dipp, M., Kumar, P., Kinnear, N. P., & Hardie, D. G. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m510040200 · Cited by 191
Cicerchi, C., Li, N., Kratzer, J. T., García, G., Roncal-Jiménez, C. A., Tanabe, K., Hunter, B., Rivard, C. J., Sautin, Y. Y., Gaucher, E. A., et al. (2014) · The FASEB Journal · doi:10.1096/fj.13-243634 · Cited by 188
Keeping the home fires burning: AMP-activated protein kinase
Hardie, D. G. (2018) · Journal of The Royal Society Interface · doi:10.1098/rsif.2017.0774 · Cited by 195
Adiponectin suppresses hepatic SREBP1c expression in an AdipoR1/LKB1/AMPK dependent pathway
Awazawa, M., Ueki, K., Inabe, K., Yamauchi, T., Kaneko, K., Okazaki, Y., Bardeesy, N. M., Ohnishi, S., Nagai, R., & Kadowaki, T. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.02.131 · Cited by 190
Regulation of the NKCC2 ion cotransporter by SPAK-OSR1-dependent and -independent pathways
Richardson, C., Sakamoto, K., Heros, P. D. L., Deák, M., Campbell, D. G., Prescott, A. R., & Alessi, D. R. (2011) · Journal of Cell Science · doi:10.1242/jcs.077230 · Cited by 186
Fetuin A in nonalcoholic fatty liver disease: in vivo and in vitro studies
Haukeland, J. W., Dahl, T. B., Yndestad, A., Gladhaug, I. P., Løberg, E. M., Haaland, T., Konopski, Z., Wium, C., Aasheim, E. T., Johansen, O. E., et al. (2011) · European Journal of Endocrinology · doi:10.1530/eje-11-0864 · Cited by 187
Zhang, J., Dong, J., Martin, M., He, M., Gongol, B., Marin, T., Chen, L., Shi, X., Yin, Y., Shang, F., et al. (2018) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201712-2570oc · Cited by 190
Metformin suppresses intestinal polyp growth in Apc Min/+ mice
Tomimoto, A., Endo, H., Sugiyama, M., Fujisawa, T., Hosono, K., Takahashi, H., Nakajima, N., Nagashima, Y., Wada, K., Nakagama, H., et al. (2008) · Cancer Science · doi:10.1111/j.1349-7006.2008.00933.x · Cited by 185
Ahmed, M. H., & Byrne, C. D. (2007) · Drug Discovery Today · doi:10.1016/j.drudis.2007.07.009 · Cited by 185
Beauloye, C., Bertrand, L., Horman, S., & Hue, L. (2011) · Cardiovascular Research · doi:10.1093/cvr/cvr034 · Cited by 191
Li, L., Mamputu, J., Wiernsperger, N. F., & Renier, G. (2005) · Diabetes · doi:10.2337/diabetes.54.7.2227 · Cited by 185
COVID-19 y diabetes mellitus: una relación bidireccional
Lima-Martínez, M. M., Boada, C. C., Madera-Silva, M. D., Marín, W., & Contreras, M. (2020) · Clínica e Investigación en Arteriosclerosis · doi:10.1016/j.arteri.2020.10.001 · Cited by 206
Sutinen, J., Häkkinen, A.-M., Westerbacka, J., Seppälä-Lindroos, A., Vehkavaara, S., Halavaara, J., Järvinen, A., Ristola, M., & Yki-Järvinen, H. (2002) · AIDS · doi:10.1097/00002030-200211080-00011 · Cited by 184
Regulation of Snf1 Protein Kinase in Response to Environmental Stress
Hong, S. P., & Carlson, M. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m700146200 · Cited by 184
Glioma-Initiating Cell Elimination by Metformin Activation of FOXO3 via AMPK
Sato, A., Sunayama, J., Okada, M., Watanabe, E., Seino, S., Shibuya, K., Suzuki, K., Narita, Y., Shibui, S., Kayama, T., et al. (2012) · Stem Cells Translational Medicine · doi:10.5966/sctm.2012-0058 · Cited by 189
Chen, G., Liu, P., Pattar, G. R., Tackett, L., Bhonagiri, P., Strawbridge, A. B., & Elmendorf, J. S. (2005) · Molecular Endocrinology · doi:10.1210/me.2005-0255 · Cited by 184
Yoon, J. Y., Kwon, H. H., Min, S. U., Thiboutot, D. M., & Suh, D. H. (2013) · Journal of Investigative Dermatology · doi:10.1038/jid.2012.292 · Cited by 183
Etoposide Induces ATM-Dependent Mitochondrial Biogenesis through AMPK Activation
Fu, X., Wan, S., Lyu, Y. L., Liu, L. F., & Qi, H. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002009 · Cited by 183
Geraghty, K. M., Chen, S., Harthill, J. E., Ibrahim, A. F., Toth, R., Morrice, N. A., Vandermoere, F., Moorhead, G. B., Hardie, D. G., & MacKintosh, C. (2007) · Biochemical Journal · doi:10.1042/bj20070649 · Cited by 181
Metadata
- Authors
- Zhou, G., Myers, R., Li, Y., Chen, Y., Shen, X., Fenyk-Melody, J., Wu, M., Ventre, J., Doebber, T., Fujii, N., Musi, N., Hirshman, M. F., Goodyear, L. J., & Moller, D. E.
- Affiliations
- Merck & Co., Inc., Rahway, NJ, USA (United States) (US)
- Corresponding author
- Zhou, Gaochao
- ORCID
- Venue
- Journal of Clinical Investigation
- Published
- 2001-10-15
- Volume
- 108
- Issue
- 8
- Pages
- 1167-1174
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC209533
- OpenAlex
- W2138226825
- Cited by
- 5,652
- References
- 36
- Citations by year
- 2026: 149 · 2025: 182 · 2024: 198 · 2023: 234 · 2022: 270 · 2021: 312 · 2020: 272 · 2019: 310 · 2018: 306 · 2017: 304 · 2016: 296 · 2015: 331 · 2014: 307 · 2013: 295 · 2012: 291
- FWCI
- 26.36
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Natural Antidiabetic Agents Studies
- Keywords
- metformin, AMPK, type 2 diabetes, hepatic glucose production, acetyl-CoA carboxylase, SREBP1, lipogenesis, fatty acid oxidation, glucose uptake, skeletal muscle, hepatic lipid metabolism, AMPK inhibitors
- MeSH terms
- Aminoimidazole Carboxamide, Animals, Diabetes Mellitus, Type 2, DNA-Binding Proteins, Enzyme Activation, Fatty Acids, Glucose, Humans, Hypoglycemic Agents, Male, Metformin, Multienzyme Complexes, Protein Kinases, Pyrazoles, Pyrimidines, Ribonucleotides, RNA, Messenger, Transcription Factors, Gene Expression, Rats, Sprague-Dawley, Protein Serine-Threonine Kinases, Muscle, Skeletal, CCAAT-Enhancer-Binding Proteins, Hepatocytes, Protein Kinase Inhibitors, Rats, Sterol Regulatory Element Binding Protein 1, AMP-Activated Protein Kinases, In Vitro Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review